Updates in Disease Mechanisms and Targeted Therapies for Atopic Dermatitis

Yellow-colored, spherical, methicillin-resistant, Staphylococcus aureus (MRSA) bacteria phagocytized by a blue-colored human white blood cell

Yellow-colored, spherical, methicillin-resistant, Staphylococcus aureus (MRSA) bacteria phagocytized by a blue-colored human white blood cell

Who

Dermatologists, pediatric dermatologists, primary care physicians, pediatricians, allergists, and other healthcare providers who treat patients with atopic dermatitis

Why

Clinicians who may be unfamiliar with atopic dermatitis may misdiagnose AD and delay treatment, resulting in pediatric patients who are irritable and cannot sleep.

How

An expert in pediatric dermatology interprets the latest evidence on the causes of AD with animated sequences illustrating how particular agents target inflammation.

Result

Clinicians whose patients who have AD know which agents are most effective

Format

Video on demand

Previous
Previous

Therapeutic Strategies in the Management of Mild-to-Moderate Atopic Dermatitis

Next
Next

Preventing HIV Infection: One Sexual History at a Time